BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38255928)

  • 1. Preoperative Factors for Lymphovascular Invasion in Prostate Cancer: A Systematic Review and Meta-Analysis.
    Karwacki J; Stodolak M; Nowak Ł; Kiełb P; Krajewski W; Lemiński A; Szydełko T; Małkiewicz B
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
    Yee DS; Shariat SF; Lowrance WT; Maschino AC; Savage CJ; Cronin AM; Scardino PT; Eastham JA
    BJU Int; 2011 Aug; 108(4):502-7. PubMed ID: 21050364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of lymphovascular invasion in patients with prostate cancer following radical prostatectomy and its association with their clinicopathological features: An updated PRISMA-compliant systematic review and meta-analysis.
    Jiang W; Zhang L; Wu B; Zha Z; Zhao H; Jun Y; Jiang Y
    Medicine (Baltimore); 2018 Dec; 97(49):e13537. PubMed ID: 30544460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative red cell distribution width is associated with postoperative lymphovascular invasion in prostate cancer patients treated with radical prostatectomy: A retrospective study.
    Wang F; Liang J; Yang F; Liu F; Han S; Xing N
    Front Endocrinol (Lausanne); 2022; 13():1020655. PubMed ID: 36313761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group).
    Kawase M; Ebara S; Tatenuma T; Sasaki T; Ikehata Y; Nakayama A; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Inoue T; Kitamura H; Saito K; Koga F; Urakami S; Koie T
    Ann Surg Oncol; 2024 Mar; 31(3):2154-2162. PubMed ID: 38200385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in lymph node-positive prostate cancer.
    Hofer MD; Kuefer R; Huang W; Li H; Bismar TA; Perner S; Hautmann RE; Sanda MG; Gschwend JE; Rubin MA
    Urology; 2006 May; 67(5):1016-21. PubMed ID: 16698361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
    Ng J; Mahmud A; Bass B; Brundage M
    BJU Int; 2012 Nov; 110(10):1507-14. PubMed ID: 22502733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy.
    Fajkovic H; Mathieu R; Lucca I; Hiess M; Hübner N; Al Hussein Al Awamlh B; Lee R; Briganti A; Karakiewicz P; Lotan Y; Roupret M; Rink M; Kluth L; Loidl W; Seitz C; Klatte T; Kramer G; Susani M; Shariat SF
    Urol Oncol; 2016 May; 34(5):233.e1-6. PubMed ID: 26973136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens.
    May M; Kaufmann O; Hammermann F; Loy V; Siegsmund M
    BJU Int; 2007 Mar; 99(3):539-44. PubMed ID: 17155973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular invasion is an independent predictor of prostate-specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer.
    Yamamoto S; Kawakami S; Yonese J; Fujii Y; Ohkubo Y; Suyama T; Komai Y; Kijima T; Ishikawa Y; Fukui I
    Int J Urol; 2008 Oct; 15(10):895-9. PubMed ID: 18721204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perineural Invasion and Lymphovascular Invasion are Associated with Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy.
    Kang M; Oh JJ; Lee S; Hong SK; Lee SE; Byun SS
    Ann Surg Oncol; 2016 Aug; 23(8):2699-706. PubMed ID: 26965702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion in prostate cancer: prognostic significance in patients treated with radiotherapy after radical prostatectomy.
    Brooks JP; Albert PS; O'Connell J; McLeod DG; Poggi MM
    Cancer; 2006 Apr; 106(7):1521-6. PubMed ID: 16518811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.
    Galiabovitch E; Hovens CM; Peters JS; Costello AJ; Battye S; Norden S; Ryan A; Corcoran NM
    BJU Int; 2017 Apr; 119(4):567-572. PubMed ID: 27431748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
    Van den Broeck T; van den Bergh RCN; Arfi N; Gross T; Moris L; Briers E; Cumberbatch M; De Santis M; Tilki D; Fanti S; Fossati N; Gillessen S; Grummet JP; Henry AM; Lardas M; Liew M; Rouvière O; Pecanka J; Mason MD; Schoots IG; van Der Kwast TH; van Der Poel HG; Wiegel T; Willemse PM; Yuan Y; Lam TB; Cornford P; Mottet N
    Eur Urol; 2019 Jun; 75(6):967-987. PubMed ID: 30342843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.
    Özsoy M; D'Andrea D; Moschini M; Foerster B; Abufaraj M; Mathieu R; Briganti A; Karakiewicz PI; Roupret M; Seitz C; Czech AK; Susani M; Shariat SF
    Urol Oncol; 2018 Apr; 36(4):158.e1-158.e6. PubMed ID: 29288003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion is a pathological feature related to aggressive cancer behavior and predicts early recurrence in prostate cancer.
    Luo HL; Chiang PH; Chen YT; Cheng YT
    Kaohsiung J Med Sci; 2012 Jun; 28(6):327-30. PubMed ID: 22632888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion as a predictor of disease progression in prostate cancer.
    Herman CM; Wilcox GE; Kattan MW; Scardino PT; Wheeler TM
    Am J Surg Pathol; 2000 Jun; 24(6):859-63. PubMed ID: 10843289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
    Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
    Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen.
    Freedland SJ; Terris MK; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Aronson WJ;
    J Urol; 2004 Jun; 171(6 Pt 1):2215-20. PubMed ID: 15126788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin.
    Kang YJ; Kim HS; Jang WS; Kwon JK; Yoon CY; Lee JY; Cho KS; Ham WS; Choi YD
    BMC Cancer; 2017 May; 17(1):321. PubMed ID: 28482884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.